Markets:

Overview

News

Currencies

International

Treasuries

Personalis, Inc. - Common Stock (NQ:PSNL)

15.88 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Personalis, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Earnings Scheduled For February 23, 2023 ↗

February 23, 2023

Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.

Via Benzinga

Earnings Outlook For Personalis ↗

February 22, 2023

Via Benzinga

Personalis to Announce Fourth Quarter and Full Year 2022 Financial Results

February 09, 2023

From Personalis, Inc.

Via Business Wire

Personalis to Participate at Upcoming Investor Conferences

February 06, 2023

From Personalis, Inc.

Via Business Wire

Analyst Upgrades Personalis; Says Biopharma Is Strong, Cash Burn Is Down ↗

February 06, 2023

Via Benzinga

Why Personalis Shares Are Trading Higher Today ↗

February 03, 2023

Via Benzinga

Cancer Genomics-Focused Personalis To Reduce Nearly One-Third Of Its Workforce ↗

January 19, 2023

Via Benzinga

Personalis's Return On Capital Employed Overview ↗

November 16, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

October 20, 2022

Thursday saw 177 companies set new 52-week lows.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 6, 2023 ↗

February 06, 2023

Via Benzinga

Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials

February 03, 2023

From Personalis, Inc.

Via Business Wire

Personalis Reports Preliminary Fourth Quarter and Full Year 2022 Revenue

January 04, 2023

From Personalis, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 26, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

December 22, 2022

Thursday's session saw 329 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

December 21, 2022

On Wednesday, 152 stocks made new 52-week lows.

Via Benzinga

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 16, 2022

From Personalis, Inc.

Via Business Wire

Personalis Announces CEO Retirement and Transition

December 14, 2022

From Personalis, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

December 20, 2022

On Tuesday, 298 companies achieved new lows for the year.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 01, 2022

Via Benzinga

Personalis and UCSF to Study Clinical Utility of ctDNA for Treatment Response in Colorectal Cancer

November 30, 2022

From Personalis, Inc.

Via Business Wire

Personalis to Present at the 34th Annual Piper Sandler Healthcare Conference

November 21, 2022

From Personalis, Inc.

Via Business Wire

Personalis Presents Data from New Platform Features at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting

November 07, 2022

From Personalis, Inc.

Via Business Wire

Personalis Reports Third Quarter 2022 Financial Results

November 02, 2022

From Personalis, Inc.

Via Business Wire

Personalis Grows Leadership Team with Appointment of Christopher Hall as Senior Vice President and Head, Diagnostics Business

October 31, 2022

From Personalis, Inc.

Via Business Wire

Personalis to Announce Third Quarter 2022 Financial Results

October 19, 2022

From Personalis, Inc.

Via Business Wire

Personalis Forms Research Collaboration to Better Predict Immunotherapy Response for Gastroesophageal Cancer

October 04, 2022

From Personalis, Inc.

Via Business Wire

121 Stocks That Hit Their 52-Week Low ↗

October 14, 2022

New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows.

Via Benzinga

Personalis to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

August 30, 2022

From Personalis, Inc.

Via Business Wire

Personalis Adds New MRD Patent Covering the Combination of Tumor-Informed and Database-Derived Content to Patent Infringement Complaint Against Foresight Diagnostics

August 17, 2022

From Personalis, Inc.

Via Business Wire

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 16, 2022

From Personalis, Inc.

Via Business Wire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.